Search for: "King v. Merck " Results 1 - 20 of 53
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jan 2007, 6:20 pm
King Pharmaceuticals (Westlaw cite is 2006 WL 3716920), and the case number is WDQ-04-3521The blog had noted: the Court [in Merck v. [read post]
3 Oct 2011, 7:43 pm
Merck said today that a federal court jury in New York found in its favor in the Secrest v. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
by Dennis Crouch Substantive Patent Law: Newly filed petition in Merck & Cie v. [read post]
17 Sep 2007, 2:00 pm
See Aventis Pharma Deutschland Gmbh and King Pharmaceuticals, Inc., v. [read post]
8 Nov 2018, 3:04 am
For practitioners the message was that whilst there may be a grace period for adjustments post-Brexit, it may be wiser to take action now in order to avoid issues such as being unable to service clients, and the rush to meet EUIPO guides that will likely incur high costs.The Keynote: Key Trade Mark Cases of the Last 12 monthsBenet Brandreth QC (11 South Square) gave an enthusiastic review of some of the most interesting Trade Mark cases in the last 12 months; such as Cartier v B Sky B;… [read post]
17 Mar 2010, 8:18 am by Joe Consumer
A is for Alpharma, a unit of King Pharmaceuticals, which according to the U.S. [read post]
25 Mar 2010, 11:00 am by Dionne Searcey
He also said the attorneys who take the lead in Toyota must be willing to spare no expense and noted how his firm had put up $13 million for the litigation against Merck for wrongful death suits for pain-killer Vioxx. [read post]
30 Nov 2015, 3:34 am
This is what happened last week:* When words mean what they say: Bob Marley copyrights stay where they areKatfriend and occasional contributor Dorothea Thompson reports on BSI Enterprises Ltd & Another v Blue Mountain Music Ltd [2015] EWCA Civ 1151, a 18 November ruling of the Court of Appeal, England and Wales, applying the principles of contractual interpretation in the context of a fairly complex music copyright assignments involving some the much-missed… [read post]
25 Apr 2010, 5:52 pm by FDABlog HPM
  The FTC’s Annual Report focuses on three cases the Commission has been involved in concerning patent settlement agreements: King Drug Co. of Florence, Inc. v. [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
10 Aug 2010, 8:44 pm by Marie Louise
  Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]